title: Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?
authors: 1 Epicentre Paris, France.
authors: Mathieu
authors: M
authors: Bastard
authors: Maryline
authors: M
authors: Bonnet
authors: Philipp
authors: P
authors: du Cros
authors: Atadjan Karimovich
authors: AK
authors: Khamraev
authors: Armen
authors: A
authors: Hayrapetyan
authors: Kamene
authors: K
authors: Kimenye
authors: Shazina
authors: S
authors: Khurkhumal
authors: Themba
authors: T
authors: Dlamini
authors: Alex
authors: A
authors: Telnov
authors: Elisabeth
authors: E
authors: Sanchez-Padilla
authors: Cathy
authors: C
authors: Hewison
authors: Francis
authors: F
authors: Varaine
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001136:Armenia; D013541:Eswatini; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy; D005260:Female; D005846:Georgia (Republic); D006801:Humans; D007630:Kenya; D008297:Male; D055118:Medication Adherence; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D014610:Uzbekistan
chemical_list: D000995:Antitubercular Agents